STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #115 by analyst upside · 2026-06-27
VERU
Veru Inc.
Healthcare · Market Cap $48M · P/E 0x
ANALYST PRICE TARGET
+714.0%
implied upside to consensus target
Current Price $3.01
Consensus Target $24.5
Bull Target $25.0
Bear Target $24.0
Analysts Covering 2
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
2
Hold
0
Sell
0
52-Week Low $2.05
52-Week High $7.33
YTD Return +32.6%
FUNDAMENTALS
Market Cap $48M
P/E Ratio (TTM) N/A
Forward P/E -3.1x
EPS (TTM) $-0.80
PEG Ratio 3.60
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $2.05
52-Week High $7.33
Current Price $3.01
Bear Target $24.0
Bull Target $25.0
● Now $3.01 ● Target $24.5
TRADING DATA
Avg Volume 1.9M
YTD Return +32.6%
Analyst Count 2
Consensus Buy
Upside to Target +714.0%
Last Updated 2026-06-27

ANALYST SUMMARY

Veru Inc. (VERU) is currently trading at $3.01 with a Wall Street consensus price target of $24.5, implying potential upside of 714.0% over the next 12 months. 2 analysts currently cover VERU, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $25.0, while the most cautious has a target of $24.0.

VERU operates in the Healthcare sector with a market capitalisation of $48M. The stock is up 32.6% year-to-date and is currently trading near the lower end of its 52-week range of $2.05 – $7.33.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VERU, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity — Reiterated
Buy → Buy 2026-06-04 Building track record
Oppenheimer — Reiterated
Outperform → Outperform 2026-05-15 14% win rate (7 calls)
Canaccord Genuity ● Initiated
Buy 2025-12-18 Building track record
Raymond James — Reiterated
Outperform → Outperform 2025-08-13 Building track record
HC Wainwright & Co. reit
Buy → Buy 2025-01-02 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2024-12-20 31% win rate (48 calls)
Oppenheimer reit
Outperform → Outperform 2024-11-05 14% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
58
out of 100
Coverage depth
8/30
Consensus clarity
23/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →